Avila-Parcet, Aina
Martín-Blanco, Ana
Gawron, Leonor
Cano, Marta
Peña-Arteaga, Víctor De la
Carceller-Sindreu, Mar
Soler, Joaquim
Portella, Maria J.
Faustino, Gloria
Cardoner, Narcís
Carmona i Farrés, Cristina
Funding for this research was provided by:
Carlos III Health Institute (CD20/00189)
European Union-NextGenerationEU/PRTR (JDC2022-048445-I)
Fundació La Marató de TV3 (202231-10)
Article History
Received: 13 May 2024
Accepted: 14 April 2025
First Online: 18 April 2025
Declarations
:
: This study is approved by the Ethical Committee for Clinical Research (in Spanish, Comité Ético de Investigación Clínica) from the Hospital de la Santa Creu i Sant Pau , project number IIBSP-TDC-2022-123. Protocol version 3, 14th July 2023.Central Clinical Research and Clinical Trials Unit (CCRCTU), Research Institute of the Hospital de Sant Pau, will monitor through periodic visits the correct progression of the project, alerting from protocol deviations. They will be constantly aware of every single step of the project.All participants will receive extended information about the study and must give their written informed consent prior to participate in the study. This study does not pose any risk to the participants.
: Written informed consent from participants will be obtained prior to the inclusion to the study.
: The authors declare no competing interests.